Detailed medical history was taken with special emphasis on age of onset and duration of the disease, frequency of epileptic attacks and number of hospital admissions due to severe attacks, as well as history of antiepileptic drugs (AEDs) (drug name, number of drugs, dosage, and duration of therapy)
Semaglutide (marketed as 'Ozempic' and 'Wegovy') and the dual-agonist Tirzepatide ('Mounjaro' and 'Zepbound') are some of today's most talked-about medications, given their unprecedented clinical efficacies across both weight loss and T2D management
Both authors declare that they have no conflicts of interest
High dose L-carnitine improves immunologic and metabolic parameters in AIDS patients
The Miami market for peptide therapy is competitive but mature, which keeps pricing aligned with national medical-clinic benchmarks
Glucagon-like peptide-1 (GLP-1) receptor agonists, FDA-approved medications for type 2 diabetes and obesity, are increasingly recognized for potential anti-inflammatory properties beyond their metabolic effects